| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.3M | +8.6% |
| R&D Expense | $18.6M | -13.1% |
| SG&A Expense | $40.8M | +15.2% |
| Operating Income | -$84.9M | -54.6% |
| Pre-tax Income | -$83.0M | -465.6% |
| Income Tax | $669K | +161.5% |
| Net Income | -$83.7M | -451.7% |
| EPS (Basic) | -$0.58 | -441.2% |
| EPS (Diluted) | -$0.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.3M | -25.4% |
| Accounts Receivable | $19.2M | +18.9% |
| Inventory | $866K | -5.0% |
| Current Assets | $139.2M | -25.6% |
| Total Assets | $378.0M | -18.1% |
| Current Liabilities | $12.5M | -2.4% |
| Total Liabilities | $39.7M | +0.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.8M | +15.8% |
| Capital Expenditures | $9.0M | -91.2% |
| Investing Cash Flow | $28.6M | +8.9% |
| Financing Cash Flow | $3.6M | +2335.6% |
| Free Cash Flow | -$59.8M | +63.2% |
| -441.2% |
| Stockholders' Equity |
| $338.4M |
| -19.9% |